Sarah and Jess are back! Kicking off 2025 in style with a whole episode about Lenacapvir, the long-acting HIV prevention medication that could be a huge game-changer for helping reach the target of no new HIV transmissions by 2030. Lenacapavir is listed as a "breakthrough technology" for 2025, so get listening and finding out what it's all about!
Sources
Twice-yearly HIV injection can effectively prevent infection
Anti-HIV drug lenacapavir called 'breakthrough of the year' : Goats and Soda : NPR
About Pre-Exposure Prophylaxis (PrEP) - NHS
PEP (post-exposure prophylaxis for HIV) | Terrence Higgins Trust
Frequently Asked Questions about UU.pdf
News
WHO announces the development of new guidelines for lenacapavir and updated HIV testing guidelines
Long-acting HIV prevention meds: 10 Breakthrough Technologies 2025 | MIT Technology Review
Hosted on Acast. See acast.com/privacy for more information.
